STAT Plus: Alnylam announces more positive data for a new RNAi drug candidate
KRISTOFFER TRIPPLAAR/SIPA USA/AP
The drug candidate, givosiran, takes aim at a family of rare diseases known as acute hepatic porphyrias, which can cause abdominal issues that can be fatal.
.png)
No hay comentarios:
Publicar un comentario